Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/77870

Registo completo
Campo DCValorIdioma
dc.contributor.authorDecante, Guypor
dc.contributor.authorOliveira, J. M.por
dc.contributor.authorReis, R. L.por
dc.contributor.authorCorreia, Joana Silvapor
dc.date.accessioned2022-05-24T14:08:36Z-
dc.date.issued2021-09-
dc.date.submitted2021-03-
dc.identifier.citationDecante G., Oliveira J. M., Reis R. L., Silva-Correia J. Injectable Polymeric Systems Based on Polysaccharides for Therapy, Polysaccharides of Microbial Origin, doi:10.1007/978-3-030-35734-4_55-1, 2021por
dc.identifier.isbn978-3-030-35734-4por
dc.identifier.urihttps://hdl.handle.net/1822/77870-
dc.description.abstractMicrobial polysaccharides are inexpensive natural polymers synthesized by various microorganisms such as bacteria, fungi, and microalgae. They have been generally used in the food industry as emulsifier, gelling agents, and thickeners. Nowadays, their favourable biological properties, similarity to native ECM, and wide range of molecular weights, and functional groups have sparked the interest of researchers for their use as injectable scaffolds used in drug delivery, tissue engineering and regenerative medicine. Notable applications of microbial polysaccharides are vaccine preparations and intra-articular injections of hydrogels in osteoarthritis therapy. These systems provide minimally invasive routes of implantation in vivo to locally deliver drugs, cells, and other therapeutics in a controlled manner. They may also provide a stable environment to support cell differentiation and migration to enhance tissue regeneration. The various uses of microbial polysaccharides and their derivatives as injectable scaffolds used in therapy are reviewed herein.por
dc.description.sponsorshipThe authors acknowledge the financial support provided through the projects B-FABULUS (PTDC/BBB-ECT/2690/2014) and Fun4TE (PTDC/EMD-EMD/31367/2017), financed by the Portuguese Foundation for Science and Technology (FCT) and co-financed by European Regional Development Fund (FEDER) and Operational Programme for Competitiveness and Internationalisation (POCI). This work has been co-funded through the project 3BioMeD (FCT/4773/4/5/2017/S). G. Decante acknowledges for his research fellowship (BI_ PTDC/BBB-ECT/2690/2014_2020_01) attributed under B-FABULUS project. The FCT distinction attributed to J. Silva-Correia Oliveira (IF/00115/2015) under the Investigator FCT program is also greatly acknowledged.por
dc.language.isoengpor
dc.publisherSpringerpor
dc.relationinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBBB-ECT%2F2690%2F2014/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FEMD-EMD%2F31367%2F2017/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBBB-ECT%2F2690%2F2014/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/Investigador FCT/IF%2F00115%2F2015%2FCP1294%2FCT0005/PTpor
dc.rightsrestrictedAccesspor
dc.subjectBacteriapor
dc.subjectDrug deliverypor
dc.subjectHydrogelspor
dc.subjectPolysaccharidespor
dc.subjectTissue engineeringpor
dc.titleInjectable polymeric systems based on polysaccharides for therapypor
dc.typebookPartpor
dc.peerreviewedyes-
dc.relation.publisherversionhttps://link.springer.com/referenceworkentry/10.1007%2F978-3-030-35734-4_55-1por
dc.commentshttp://3bs.uminho.pt/node/20504por
oaire.citationStartPage1por
oaire.citationEndPage18por
dc.date.updated2022-05-18T10:22:45Z-
dc.identifier.doi10.1007/978-3-030-35734-4_55-1por
dc.date.embargo10000-01-01-
sdum.bookTitlePolysaccharides of microbial originpor
Aparece nas coleções:3B’s - Capítulos de Livros/Book Chapters

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
20504-decante2021-referenceworkentry-injectablepolymericsystembased.pdf
Acesso restrito!
426,18 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID